Article

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s Disease

2026-03-09

Abstract excerpt

Despite a growing body of evidence implicating genetic variants and proteins encoded by them with risk and pathogenesis of Alzheimer’s disease (AD), this knowledge has not been successfully translated into effective AD treatments. We integrated current genomic, transcriptomic and proteomic profiles of AD into a network pharmacology framework that leverages comprehensive gene-gene and drug-target interactions. This...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 33898012-c6f0-53e4-907a-6aed480ab05a
DOI: 10.64898/2026.03.05.709917

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseDOI 10.64898/2026.03.05.709917Read

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read

Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.Semantic proximity Read

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer’s diseaseSemantic proximity Read

Identification of potential drug targets for Alzheimer's disease from genetic insights: A Mendelian randomization study.Semantic proximity Read

Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer’s DiseaseSemantic proximity Read

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s diseaseSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read

Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity Read

Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer DiseaseSemantic proximity Read

Network Pharmacology-guided Identification and Molecular Validation of Multi-Target Phytoconstituents from Gmelina arborea against Alzheimer’s DiseaseSemantic proximity Read

Machine Learning Identifies Novel Candidates for Drug Repurposing in Alzheimer’s DiseaseSemantic proximity Read

Integrative Transcriptomic Analysis Identifies Conserved Molecular Signatures and Drug Repurposing Candidates in Alzheimer’s DiseaseSemantic proximity Read